Market Research Report
Lipid Disorder Treatment
|Published by||Global Industry Analysts, Inc.||Product code||997645|
|Published||Content info||138 Pages
Delivery time: 1-2 business days
|Lipid Disorder Treatment|
|Published: April 1, 2021||Content info: 138 Pages||
Global Lipid Disorder Treatment Market to Reach $36 Billion by 2027
Amid the COVID-19 crisis, the global market for Lipid Disorder Treatment estimated at US$23.6 Billion in the year 2020, is projected to reach a revised size of US$36 Billion by 2027, growing at a CAGR of 6.2% over the period 2020-2027.
The U.S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 9.4% CAGR
The Lipid Disorder Treatment market in the U.S. is estimated at US$6.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.7 Billion by the year 2027 trailing a CAGR of 9.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
Select Competitors (Total 42 Featured) -